These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31301562)

  • 1. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
    Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.
    De Felice FG; Velasco PT; Lambert MP; Viola K; Fernandez SJ; Ferreira ST; Klein WL
    J Biol Chem; 2007 Apr; 282(15):11590-601. PubMed ID: 17308309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
    Song G; Li Y; Lin L; Cao Y
    Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
    Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
    Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
    Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
    Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals.
    Chen TF; Tang MC; Chou CH; Chiu MJ; Huang RF
    Food Chem Toxicol; 2013 Dec; 62():538-47. PubMed ID: 24055771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
    Rush T; Buisson A
    Cell Tissue Res; 2014 May; 356(2):279-86. PubMed ID: 24496511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
    Danysz W; Parsons CG
    Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review.
    Phadke AV; Tayade AA; Khambete MP
    Chem Biol Drug Des; 2021 Nov; 98(5):713-721. PubMed ID: 34240555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.
    Birnbaum JH; Bali J; Rajendran L; Nitsch RM; Tackenberg C
    Cell Death Dis; 2015 Jun; 6(6):e1791. PubMed ID: 26086964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease.
    Singh YP; Kumar H
    Chem Biol Drug Des; 2024 Oct; 104(4):e14638. PubMed ID: 39370170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.